{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T13:00:02Z","timestamp":1784293202142,"version":"3.55.0"},"reference-count":160,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>CD73, an important metabolic and immune escape-promoting gene, catalyzes the hydrolysis of adenosine monophosphate (AMP) to adenosine (ADO). AMP has anti-inflammatory and vascular relaxant properties, while ADO has a strong immunosuppressive effect, suggesting that CD73 has pro-inflammatory and immune escape effects. However, CD73 also decreased proinflammatory reaction, suggesting that CD73 has a positive side to the body. Indeed, CD73 plays a protective role in diabetes, while with age, CD73 changes from anti-atherosclerosis to pro-atherosclerosis. The upregulation of CD73 with agents, including AGT-5, Aire-overexpressing DCs, Aspirin, BAFFR-Fc, CD4+ peptide, ICAs, IL-2 therapies, SAgAs, sCD73, stem cells, RAD51 inhibitor, TLR9 inhibitor, and VD, decreased diabetes and atherosclerosis development. However, the downregulation of CD73 with agents, including benzothiadiazine derivatives and CD73 siRNA, reduced atherosclerosis. Notably, many CD73 agents were investigated in clinical trials. However, no agents were used to treat diabetes and atherosclerosis. Most agents were CD73 inhibitors. Only FP-1201, a CD73 agonist, was investigated in clinical trials but its further development was discontinued. In addition, many lncRNAs, circRNAs, and genes are located at the same chromosomal location as CD73. In particular, circNT5E promoted CD73 expression. circNT5E may be a promising target for agent development. This mini-review focuses on the current state of knowledge of CD73 in diabetes, atherosclerosis, and its potential role in agent development.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1515875","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T05:12:07Z","timestamp":1733980327000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["CD73: agent development potential and its application in diabetes and atherosclerosis"],"prefix":"10.3389","volume":"15","author":[{"given":"Dan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongming","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wujun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1130358","article-title":"Tumor intrinsic and extrinsic functions of CD73 and the adenosine pathway in lung cancer","volume":"14","author":"Kowash","year":"2023","journal-title":"Front Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"111372","DOI":"10.1016\/j.cellsig.2024.111372","article-title":"Human placental mesenchymal stromal cells alleviate intestinal oxidative damage in mice with graft-versus-host disease via CD73\/adenosine\/pi3k\/akt\/gsk-3beta axis","volume":"123","author":"Han","year":"2024","journal-title":"Cell Signal"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-020-0304-7","article-title":"Conversion of extracellular atp into adenosine: a master switch in renal health and disease","volume":"16","author":"Dwyer","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2174\/0929867325666180117101114","article-title":"Role of CD73 in disease: promising prognostic indicator and therapeutic target","volume":"25","author":"Yang","year":"2018","journal-title":"Curr Med Chem"},{"key":"B5","doi-asserted-by":"publisher","first-page":"102361","DOI":"10.1016\/j.tice.2024.102361","article-title":"The impact of diabetic glucose concentration on viability and cardiac differentiation of mesenchymal stem cells","volume":"88","author":"Nosrati","year":"2024","journal-title":"Tissue Cell"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2018.06.001","article-title":"Cd90 identifies adventitial mesenchymal progenitor cells in adult human medium- and large-sized arteries","volume":"11","author":"Michelis","year":"2018","journal-title":"Stem Cell Rep"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.4252\/wjsc.v15.i9.931","article-title":"Integrin beta 3-overexpressing mesenchymal stromal cells display enhanced homing and can reduce atherosclerotic plaque","volume":"15","author":"Hu","year":"2023","journal-title":"World J Stem Cells"},{"key":"B8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3390\/vaccines11010081","article-title":"Subclinical atherosclerosis is associated with discrepancies in BAFF and April levels and altered breg potential of precursor-like marginal zone B-cells in long-term HIV treated individuals","volume":"11","author":"Aranguren","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1428551","article-title":"Protective role of the CD73-A2ar axis in cirrhotic cardiomyopathy through negative feedback regulation of the nf-kappab pathway","volume":"15","author":"Zhao","year":"2024","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/froh.2023.1308657","article-title":"The protective role of CD73 in periodontitis: preventing hyper-inflammatory fibroblasts and driving osteoclast energy metabolism","volume":"4","author":"Ramos-Junior","year":"2023","journal-title":"Front Oral Health"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biom14010001","article-title":"Altered cd39 and CD73 expression in rheumatoid arthritis: implications for disease activity and treatment response","volume":"14","author":"Ortiz","year":"2023","journal-title":"Biomolecules"},{"key":"B12","doi-asserted-by":"publisher","first-page":"112743","DOI":"10.1016\/j.intimp.2024.112743","article-title":"The reduced frequency of cd39(+)Cd73(+) B cell subsets in sle patients is correlated with disease activity","volume":"140","author":"Dong","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012101014","article-title":"CD73-dependent generation of adenosine and endothelial adora2b signaling attenuate diabetic nephropathy","volume":"25","author":"Tak","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700024","article-title":"Genetic and small molecule disruption of the aid\/rad51 axis similarly protects nonobese diabetic mice from type 1 diabetes through expansion of regulatory B lymphocytes","volume":"198","author":"Ratiu","year":"2017","journal-title":"J Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700822","article-title":"Transient BAFF blockade inhibits type 1 diabetes development in nonobese diabetic mice by enriching immunoregulatory B lymphocytes sensitive to deletion by anti-cd20 cotherapy","volume":"199","author":"Wang","year":"2017","journal-title":"J Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1454156","article-title":"Novel ahr ligand agt-5 ameliorates type 1 diabetes in mice through regulatory cell activation in the early phase of the disease","volume":"15","author":"Jonic","year":"2024","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"111852","DOI":"10.1016\/j.mce.2023.111852","article-title":"Neuromodulatory effect of the combination of metformin and vitamin D(3) triggered by purinergic signaling in type 1 diabetes induced-rats","volume":"563","author":"Pereira","year":"2023","journal-title":"Mol Cell Endocrinol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/ijms17010038","article-title":"Aire-overexpressing dendritic cells induce peripheral CD4(+) T cell tolerance","volume":"17","author":"Li","year":"2015","journal-title":"Int J Mol Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.v233.2","article-title":"Reprogramming mouse embryo fibroblasts to functional islets without genetic manipulation","volume":"233","author":"Chandravanshi","year":"2018","journal-title":"J Cell Physiol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2016.7","article-title":"Reduced interleukin-2 responsiveness impairs the ability of treg cells to compete for il-2 in nonobese diabetic mice","volume":"94","author":"James","year":"2016","journal-title":"Immunol Cell Biol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1901128","article-title":"Regulatory T cells induced by single-peptide liposome immunotherapy suppress islet-specific T cell responses to multiple antigens and protect from autoimmune diabetes","volume":"204","author":"Bergot","year":"2020","journal-title":"J Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2337\/db20-0845","article-title":"Soluble antigen arrays efficiently deliver peptides and arrest spontaneous autoimmune diabetes","volume":"70","author":"Firdessa-Fite","year":"2021","journal-title":"Diabetes"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1300547","article-title":"TLR9 deficiency promotes CD73 expression in T cells and diabetes protection in nonobese diabetic mice","volume":"191","author":"Tai","year":"2013","journal-title":"J Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0412-4081.2017.07.013","article-title":"The protective effect of pigment epithelial-derived factor modified human umbilical cord mesenchymal stem cells on rats with diabetic retinopathy","volume":"53","author":"Zhang","year":"2017","journal-title":"Zhonghua Yan Ke Za Zhi"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028175","article-title":"Differentiation of mesenchymal stem cells derived from pancreatic islets and bone marrow into islet-like cell phenotype","volume":"6","author":"Zanini","year":"2011","journal-title":"PloS One"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2017.10.013","article-title":"Transplantation routes affect the efficacy of human umbilical cord mesenchymal stem cells in a rat gdm model","volume":"475","author":"Wu","year":"2017","journal-title":"Clin Chim Acta"},{"key":"B27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1177\/0963689718808472","article-title":"Epigenetic and transcriptome profiling identifies a population of visceral adipose-derived progenitor cells with the potential to differentiate into an endocrine pancreatic lineage","volume":"28","author":"Williams","year":"2019","journal-title":"Cell Transplant"},{"key":"B28","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10561-015-9541-6","article-title":"Isolation and proliferation of umbilical cord tissue derived mesenchymal stem cells for clinical applications","volume":"17","author":"Van Pham","year":"2016","journal-title":"Cell Tissue Bank"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v12.i28.4529","article-title":"Characterization of pancreatic stem cells derived from adult human pancreas ducts by fluorescence activated cell sorting","volume":"12","author":"Lin","year":"2006","journal-title":"World J Gastroenterol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.4161\/isl.2.2.11280","article-title":"Islet neogenesis from the constitutively nestin expressing human umbilical cord matrix derived mesenchymal stem cells","volume":"2","author":"Kadam","year":"2010","journal-title":"Islets"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.24572","article-title":"Pancreatic tissue resident mesenchymal stromal cell (Msc)-like cells as a source of in vitro islet neogenesis","volume":"114","author":"Gopurappilly","year":"2013","journal-title":"J Cell Biochem"},{"key":"B32","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.tice.2018.12.001","article-title":"Multilineage potential research on pancreatic mesenchymal stem cells of bovine","volume":"56","author":"Gao","year":"2019","journal-title":"Tissue Cell"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/stem.3143","article-title":"Characterization of a vimentin(High)\/nestin(High) proteome and tissue regenerative secretome generated by human pancreas-derived mesenchymal stromal cells","volume":"38","author":"Cooper","year":"2020","journal-title":"Stem Cells"},{"key":"B34","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13287-020-01610-0","article-title":"Mesenchymal stem cell-derived exosomes protect beta cells against hypoxia-induced apoptosis via mir-21 by alleviating er stress and inhibiting P38 mapk phosphorylation","volume":"11","author":"Chen","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.4161\/isl.2.3.11449","article-title":"Isolated human islets contain a distinct population of mesenchymal stem cells","volume":"2","author":"Carlotti","year":"2010","journal-title":"Islets"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.cdtm.2017.02.006","article-title":"Effect of type 2 diabetic serum on the behavior of Wharton\u2019s jelly-derived mesenchymal stem cells in vitro","volume":"3","author":"Ali","year":"2017","journal-title":"Chronic Dis Transl Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s10735-018-9772-5","article-title":"Human urine-derived stem cells play a novel role in the treatment of STZ-induced diabetic mice","volume":"49","author":"Zhao","year":"2018","journal-title":"J Mol Histol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13287-016-0287-2","article-title":"Exosomes secreted by human urine-derived stem cells could prevent kidney complications from type I diabetes in rats","volume":"7","author":"Jiang","year":"2016","journal-title":"Stem Cell Res Ther"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.7150\/thno.22958","article-title":"Exosomal dmbt1 from human urine-derived stem cells facilitates diabetic wound repair by promoting angiogenesis","volume":"8","author":"Chen","year":"2018","journal-title":"Theranostics"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjog.2017.04.007","article-title":"Potential differentiation of islet-like cells from pregnant cow-derived placental stem cells","volume":"56","author":"Peng","year":"2017","journal-title":"Taiwan J Obstet Gynecol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000000388","article-title":"Transplantation of insulin-producing cells differentiated from human periosteum-derived progenitor cells ameliorate hyperglycemia in diabetic mice","volume":"98","author":"Dao","year":"2014","journal-title":"Transplantation"},{"key":"B42","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s12967-019-2000-6","article-title":"Kinetics of msc-based enzyme therapy for immunoregulation","volume":"17","author":"Burr","year":"2019","journal-title":"J Transl Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"15249","DOI":"10.1038\/s41598-017-14979-5","article-title":"Human gingiva-derived mesenchymal stem cells ameliorate streptozoticin-induced T1dm in mice via suppression of T effector cells and up-regulating treg subsets","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci Rep"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s11302-016-9545-0","article-title":"Regulation of CD73 in the development of lower limb atherosclerosis","volume":"13","author":"Jalkanen","year":"2017","journal-title":"Purinergic Signal"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1177\/1358863X241235669","article-title":"Pilot study to evaluate the safety and effectiveness of etidronate treatment for arterial calcification due to deficiency of CD73 (Acdc)","volume":"29","author":"Ferrante","year":"2024","journal-title":"Vasc Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1101\/2024.08.01.606196","article-title":"Rapamycin increases murine lifespan but does not reduce mineral volume in the matrix GLA protein (MGP) knockout mouse model of medial arterial calcification","author":"Behzadi","year":"2024","journal-title":"Biorxiv"},{"key":"B47","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ymgme.2011.01.018","article-title":"Vascular pathology of medial arterial calcifications in nt5e deficiency: implications for the role of adenosine in pseudoxanthoma elasticum","volume":"103","author":"Markello","year":"2011","journal-title":"Mol Genet Metab"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharep.2015.05.002","article-title":"The role of ecto-5\u2019-nucleotidase in endothelial dysfunction and vascular pathologies","volume":"67","author":"Zukowska","year":"2015","journal-title":"Pharmacol Rep"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.867176","article-title":"Endothelial-specific deletion of connexin40 promotes atherosclerosis by increasing CD73-dependent leukocyte adhesion","volume":"121","author":"Chadjichristos","year":"2010","journal-title":"Circulation"},{"key":"B50","doi-asserted-by":"publisher","first-page":"110296","DOI":"10.1016\/j.intimp.2023.110296","article-title":"Aspirin ameliorates atherosclerotic immuno-inflammation through regulating the treg\/th17 axis and cd39-CD73 adenosine signaling via remodeling the gut microbiota in apoe(-\/-) mice","volume":"120","author":"Bai","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/iub.v67.11","article-title":"CD73 regulates vascular smooth muscle cell functions and facilitates atherosclerotic plaque formation","volume":"67","author":"Yang","year":"2015","journal-title":"IUBMB Life"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1113\/tjp.2018.596.issue-15","article-title":"Ecto-5\u2019-nucleotidase (CD73) regulates peripheral chemoreceptor activity and cardiorespiratory responses to hypoxia","volume":"596","author":"Holmes","year":"2018","journal-title":"J Physiol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1080\/13543776.2018.1407756","article-title":"Evaluation of wo2017098421: gsk\u2019s benzothiazine compounds as CD73 inhibitor filings","volume":"28","author":"Gong","year":"2018","journal-title":"Expert Opin Ther Pat"},{"key":"B54","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1161\/ATVBAHA.119.313002","article-title":"Cd73 promotes age-dependent accretion of atherosclerosis","volume":"40","author":"Sutton","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.IMM2016-PR10","article-title":"Abstract pr10: small-molecule inhibitors of CD73 promote activation of human cd8+ T cells and have profound effects on tumor growth and immune parameters in experimental tumors","volume":"4","author":"Jaen","year":"2016","journal-title":"Cancer Immunol Res"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6074.TUMIMM16-B46","article-title":"Abstract B46: small-molecule inhibitors of ecto-nucleotidase CD73 promote activation of human cd8+ T cells and have profound effects on tumor growth and immune parameters in experimental tumor models","volume":"5","author":"Tan","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"B57","first-page":"A86","article-title":"A8. 12 aav mediated expression of cd39 and CD73 is effective in reducing inflammation in the air pouch synovial inflammation model","volume-title":"Ann Rheum Dis","author":"Finn","year":"2015"},{"key":"B58","unstructured":"Abbisko therapeutic completed the first patient dose in phase I clinical trial for novel small molecule CD73 inhibitor absk051\n          \n          \n          \n          2024"},{"key":"B59","doi-asserted-by":"publisher","first-page":"A1","DOI":"10.1136\/jitc-2022-SITC2022.1441","article-title":"1441 a potent and selective small molecule antagonist of CD73 absk051 reverses immunosuppression through reduction of adenosine production","volume":"10","author":"Deng","year":"2022","journal-title":"J Immunother"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2023-LB316","article-title":"Abstract LB316: A next-generation krasg12c inhibitor absk071 demonstrated broad synergy with other therapeutic agents in krasg12c mutated cancer models","volume":"83","author":"Ying","year":"2023","journal-title":"Cancer Res"},{"key":"B61","unstructured":"Science-pipeline\n          \n          \n            \n              Angarus Therapeutics\n              I\n            \n          \n          \n          2024"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2022-5526","article-title":"AK131, an anti-pd1\/CD73 bispecific antibody for cancer immune therapy","volume":"82","author":"Huang","year":"2022","journal-title":"Cancer Res"},{"key":"B63","unstructured":"Antennova to present latest data of atn-037 in a mini oral presentation at esmo congress 2024\n          \n          \n          \n          2024"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2022-2576","article-title":"Atg-037, a highly potent small molecule CD73 inhibitor has superior activity of reversing immunosuppression in higher-amp environments compared with anti-CD73 antibodies","volume":"82","author":"Bian","year":"2022","journal-title":"Cancer Res"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2023-496","article-title":"Targeting CD73-adenosine axis for the treatment of multiple myeloma","volume":"83","author":"Bian","year":"2023","journal-title":"Cancer Res"},{"key":"B66","unstructured":"APB A2\n          \n          \n          \n          2023"},{"key":"B67","unstructured":"Ap-401\u2122 Ipsc-derived bi-specific car nk cells\n          \n          \n          \n          2024"},{"key":"B68","unstructured":"Pipeline\n          \n          \n          \n          2024"},{"key":"B69","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41698-023-00356-1","article-title":"Advances in nk cell therapy for brain tumors","volume":"7","author":"Fares","year":"2023","journal-title":"NPJ Precis Oncol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-018-1240-4","article-title":"Cd73 downregulation decreases in vitro and in vivo glioblastoma growth","volume":"56","author":"Azambuja","year":"2019","journal-title":"Mol Neurobiol"},{"key":"B71","unstructured":"BB 1709\n          \n          \n          \n          2024"},{"key":"B72","unstructured":"Pipeline\n          \n          \n          \n          2024"},{"key":"B73","unstructured":"Pipeline-bp1200\n          \n          \n          \n          2024"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2022-2905","article-title":"A novel therapeutic antibody against CD73 that ameliorates the tumor microenvironment and improves the efficacy of cancer immunotherapy","volume":"82","author":"Matsumoto","year":"2022","journal-title":"Cancer Res"},{"key":"B75","unstructured":"Product pipeline diagram\n          \n          \n          \n          2024"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2023-504","article-title":"Bpi-472372: a potent and orally bioavailable small molecule inhibitor of CD73 for cancer immunotherapy","volume":"83","author":"Han","year":"2023","journal-title":"Cancer Res"},{"key":"B77","unstructured":"BioRay's new drug br101 injection was approved in clinical trials\n          \n          2021"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-006837","article-title":"Bispecific antibody CD73xegfr more selectively inhibits the CD73\/adenosine immune checkpoint on cancer cells and concurrently counteracts pro-oncogenic activities of CD73 and egfr","volume":"11","author":"Ploeg","year":"2023","journal-title":"J ImmunoTher Cancer"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2018-CT180","article-title":"Abstract CT180: preliminary phase 1 profile of bms-986179, an anti-CD73 antibody, in combination with nivolumab in patients with advanced solid tumors","volume":"78","author":"Siu","year":"2018","journal-title":"Cancer Res"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2024-2668","article-title":"Cbo421: a novel drug fc-conjugate to prevent tumor immune evasion via the CD73\/adenosine pathway","volume":"84","author":"Almaguer","year":"2024","journal-title":"Cancer Res"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-SITC2023.1195","article-title":"1195 discovery of cbo421, a first-in-class drug fc-conjugate (DFC), targeting CD73 in cancer","volume":"84","author":"Dohrmann","year":"2023","journal-title":"BMJ Specialist Journals"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2024-LB131","article-title":"Abstract lb131: cbo421, a novel drug fc-conjugate, inhibits the enzymatic activity of CD73 and triggers CD73 internalization","volume":"84","author":"Abelovski","year":"2024","journal-title":"Cancer Res"},{"key":"B83","unstructured":"CBO 421\n          \n          \n          \n          2024"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.4c00553","article-title":"Discovery of small and bifunctional molecules targeting pd-L1\/CD73 for cancer dual immunotherapy","volume":"67","author":"Wang","year":"2024","journal-title":"J Medicinal Chem"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00430.2020","article-title":"Structural and functional characterization of engineered bifunctional fusion proteins of cd39 and CD73 ectonucleotidases","volume":"320","author":"Zhong","year":"2021","journal-title":"Am J Physiol Cell Physiol"},{"key":"B86","article-title":"A8. 14 cd39 and CD73 transgenic exosomes and recombinant fusion protein as novel therapeutics for the treatment of inflammatory disease","volume-title":"Ann Rheum Dis","author":"Finn","year":"2015"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-205124.38","article-title":"A1. 39 modulation of atp: adenosine balance by exosome and rain (Recombinant anti-inflammatory fusion protein) delivery of cd39 and CD73 is effective in reducing pro-inflammatory cytokine and chemokine production","volume":"73","author":"Finn","year":"2014","journal-title":"Ann Rheumatic Dis"},{"key":"B88","unstructured":"Pipeline\n          \n          \n          \n          2024"},{"key":"B89","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.iotech.2023.100664","article-title":"153p discovery of a novel, dual CD73 and pd-1 targeting multispecific drug fc-conjugate (DFC) for the treatment of cancer","volume":"20","author":"Levin","year":"2023","journal-title":"J Immuno-Oncol Technol"},{"key":"B90","unstructured":"Our portfolio-small molecule pipeline\n          \n          \n          \n          2024"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b01713","article-title":"Discovery of potent and selective non-nucleotide small molecule inhibitors of CD73","volume":"63","author":"Beatty","year":"2020","journal-title":"J Med Chem"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2020.06.020","article-title":"Preventing atp degradation by aso-mediated knockdown of cd39 and CD73 results in A2ar-independent rescue of T cell proliferation","volume":"21","author":"Festag","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"key":"B93","unstructured":"CHS 7304\n          \n          \n          \n          2022"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.4c00825","article-title":"Discovery of novel non-nucleoside inhibitors interacting with dizinc ions of CD73","volume":"67","author":"Shi","year":"2024","journal-title":"J Medicinal Chem"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005267","article-title":"Phase 1 first-in-human study of dalutrafusp alfa, an anti-CD73-TGF-beta-trap bifunctional antibody, in patients with advanced solid tumors","volume":"11","author":"Tolcher","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B96","unstructured":"Research programme: immune-mediated cancer therapeutics - shanghai de novo pharmatech\n          \n          \n          \n          2022"},{"key":"B97","doi-asserted-by":"publisher","first-page":"Cd013825","DOI":"10.1002\/14651858.CD013825.pub2","article-title":"Sars-cov-2-neutralising monoclonal antibodies for treatment of covid-19","volume":"9","author":"Kreuzberger","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1038\/s41598-022-05771-1","article-title":"Induction of CD73 prevents death after emergency open aortic surgery for a ruptured abdominal aortic aneurysm: a randomized, double-blind, placebo-controlled study","volume":"12","author":"Hakovirta","year":"2022","journal-title":"Sci Rep"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200737793","article-title":"Ifn-beta protects from vascular leakage via up-regulation of CD73","volume":"37","author":"Kiss","year":"2007","journal-title":"Eur J Immunol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/S2213-2600(13)70259-5","article-title":"The effect of intravenous interferon-beta-1a (FP-1201) on lung CD73 expression and on acute respiratory distress syndrome mortality: an open-label study","volume":"2","author":"Bellingan","year":"2014","journal-title":"Lancet Respir Med"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.22525","article-title":"Effect of intravenous interferon beta-1a on death and days free from mechanical ventilation among patients with moderate to severe acute respiratory distress syndrome: A randomized clinical trial","volume":"323","author":"Ranieri","year":"2020","journal-title":"Jama"},{"key":"B102","unstructured":"GB 7002\n          \n          \n          \n          2024"},{"key":"B103","doi-asserted-by":"publisher","first-page":"A1181","DOI":"10.1136\/jitc-2023-SITC2023.1072","article-title":"1072 GI-108, a novel bispecific fusion protein augments anti-tumor immunity by alleviating immunosuppressive adenosine pathway in CD8+ T cells","volume":"11","author":"Shin","year":"2023","journal-title":"BMJ Specialist Journals"},{"key":"B104","unstructured":"GI 108\n          \n          \n          \n          2023"},{"key":"B105","unstructured":"HB 0039\n          \n          \n          \n          2023"},{"key":"B106","unstructured":"Product pipeline\n          \n          \n          \n          2024"},{"key":"B107","unstructured":"Good news!  Huaota independently developed the world's first targeted CD39\/CD73 bispecific antibody was entered in clinical trails by NMPA approvation\n          \n          2024"},{"key":"B108","unstructured":"Harbour biomed announces ind clearance for hbm1007 targeting CD73 in the U.S\n          \n          \n          \n          2023"},{"key":"B109","unstructured":"Henlius received IND approval for its novel anti-CD73 mAb HLX23 from US FDA\n          \n          \n          \n          2021"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2022.12.258","article-title":"Pharmacology, pharmacokinetics, and toxicity characterization of a novel anti-CD73 therapeutic antibody ibi325 for cancer immunotherapy","volume":"229","author":"Zhou","year":"2023","journal-title":"Int J Biol Macromol"},{"key":"B111","unstructured":"INCA 00186\n          \n          \n          \n          2023"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2021-1877","article-title":"IOA-237-A potent anti-CD73 mAb demonstrates monotherapeutic and combination efficacy in solid tumor models","volume":"81","author":"Deken","year":"2021","journal-title":"Cancer Res"},{"key":"B113","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1016\/j.celrep.2019.04.091","article-title":"Blocking antibodies targeting the cd39\/CD73 immunosuppressive pathway unleash immune responses in combination cancer therapies","volume":"27","author":"Perrot","year":"2019","journal-title":"Cell Rep"},{"key":"B114","doi-asserted-by":"publisher","first-page":"115184","DOI":"10.1016\/j.biopha.2023.115184","article-title":"Drugs targeting adenosine signaling pathways: a current view","volume":"165","author":"Kutryb-Zaj\u0105c","year":"2023","journal-title":"BioMed Pharmacother"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2023-2923","article-title":"JAB-X1800: A potent immunostimulatory antibody-drug conjugate (IADC) targeting CD73","volume":"83","author":"Ye","year":"2023","journal-title":"Cancer Res"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2023.12.004","article-title":"The inhibitory effect of adenosine on tumor adaptive immunity and intervention strategies","volume":"14","author":"Wang","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-21-0107","article-title":"A novel antagonistic CD73 antibody for inhibition of the immunosuppressive adenosine pathway","volume":"20","author":"Wurm","year":"2021","journal-title":"Mol Cancer Ther"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.TPS2646","article-title":"A phase I\/ib multicenter study to evaluate the humanized anti-CD73 antibody, CPI-006, as A single agent, in combination with CPI-444, and in combination with pembrolizumab in adult patients with advanced cancers","volume":"37","author":"Mobasher","year":"2019","journal-title":"Am Soc Of Clin Oncol"},{"key":"B119","first-page":"2.937","article-title":"Preclinical and initial phase I clinical characterization of CPI-006: an anti-CD73 monoclonal antibody with unique immunostimulatory activity","volume":"58","author":"Piccione","year":"2018","journal-title":"Prostate"},{"key":"B120","doi-asserted-by":"publisher","first-page":"10.1200","DOI":"10.1200\/JCO.2019.37.15_suppl.2505","article-title":"Immunobiology, preliminary safety, and efficacy of CPI-006, an anti-CD73 antibody with immune modulating activity, in a phase 1 trial in advanced cancers","volume":"37","author":"Luke","year":"2019","journal-title":"J Clin Oncol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1101\/2020.09.10.20191486","article-title":"Characterization and phase 1 trial of A B cell activating anti-CD73 antibody for the immunotherapy of covid-19","author":"Willingham","year":"2020","journal-title":"medRxiv"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-023-03430-6","article-title":"First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors","volume":"72","author":"Bendell","year":"2023","journal-title":"Cancer Immunol Immunother"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1208875","article-title":"Targeting CD73 in the tumor microenvironment with medi9447","volume":"5","author":"Hay","year":"2016","journal-title":"Oncoimmunology"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00227","article-title":"Coast: an open-label, phase II, multidrug platform study of durvalumab alone or in combination with oleclumab or monalizumab in patients with unresectable, stage III non-small-cell lung cancer","volume":"40","author":"Herbst","year":"2022","journal-title":"J Clin Oncol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1182\/blood-2021-148174","article-title":"Cd73 inhibition overcomes immunosuppression and triggers autologous T-cell mediated multiple myeloma cell lysis in the bone marrow milieu","volume":"138","author":"Ray","year":"2021","journal-title":"J Blood"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c01086","article-title":"Orally bioavailable small-molecule CD73 inhibitor (Op-5244) reverses immunosuppression through blockade of adenosine production","volume":"63","author":"Du","year":"2020","journal-title":"J Med Chem"},{"key":"B127","unstructured":"Pipeline\n          \n          \n          \n          2024"},{"key":"B128","unstructured":"Advancing candidates designed to address resistance mechanisms in multiple cancers\n          \n          \n          \n          2024"},{"key":"B129","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41408-024-01019-5","article-title":"A novel small molecule inhibitor of CD73 triggers immune-mediated multiple myeloma cell death","volume":"14","author":"Ray","year":"2024","journal-title":"Blood Cancer J"},{"key":"B130","unstructured":"ORIC 533\n          \n          \n          \n          2024"},{"key":"B131","unstructured":"PBF 2828\n          \n          \n          \n          2019"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1039\/D4TB00292J","article-title":"Nanoparticles targeting the adenosine pathway for cancer immunotherapy","volume":"12","author":"Jiang","year":"2024","journal-title":"J Mater Chem B"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5b00802","article-title":"Alpha,Beta-methylene-adp (Aopcp) derivatives and analogues: development of potent and selective ecto-5\u2019-nucleotidase (Cd73) inhibitors","volume":"58","author":"Bhattarai","year":"2015","journal-title":"J Med Chem"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.0c00391","article-title":"Fluorescent probes for ecto-5\u2019-nucleotidase (CD73)","volume":"11","author":"Schmies","year":"2020","journal-title":"ACS Med Chem Lett"},{"key":"B135","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1124\/pharmrev.121.000528","article-title":"ATP and adenosine metabolism in cancer: exploitation for therapeutic gain","volume":"74","author":"Yegutkin","year":"2022","journal-title":"Pharmacol Rev"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2022-4259","article-title":"Pt199, a next generation anti-CD73 mAb that inhibits both membrane-bound and soluble CD73 activity to completion without \u201cHook effect","volume":"82","author":"Jia","year":"2022","journal-title":"Cancer Res"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biochem.9b00448","article-title":"An exceptionally potent inhibitor of human CD73","volume":"58","author":"Bowman","year":"2019","journal-title":"Biochemistry"},{"key":"B138","unstructured":"Taiho pharmaceutical exercises option for an exclusive license to quemliclustat in Japan and certain territories in Asia\n          \n          \n            \n              Arcus Biosciences\n              I\n            \n          \n          \n          2024"},{"key":"B139","unstructured":"Quemliclustat - arcus biosciences\n          \n          \n          \n          2024"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2024-3737","article-title":"Molecular and early clinical characterization of the anti-CD73 antibody S095024 (Sym024)","volume":"84","author":"Spreafico","year":"2024","journal-title":"Cancer Res"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S326178","article-title":"A novel CD73 inhibitor shr170008 suppresses adenosine in tumor and enhances anti-tumor activity with pd-1 blockade in a mouse model of breast cancer","volume":"14","author":"Liu","year":"2021","journal-title":"Onco Targets Ther"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2022.2078191","article-title":"Adenosine pathway inhibitors: novel investigational agents for the treatment of metastatic breast cancer","volume":"31","author":"Rizzo","year":"2022","journal-title":"Expert Opin Investig Drugs"},{"key":"B143","unstructured":"Pipeline\n          \n          \n          \n          2024"},{"key":"B144","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2021.39.15_suppl.2511","article-title":"Preliminary safety, pharmacokinetics (PK), pharmacodynamics (PD) and clinical efficacy of uliledlimab (TJ004309), a differentiated CD73 antibody, in combination with atezolizumab in patients with advanced cancer","volume-title":"J Clin Oncol","author":"Robert","year":"2021"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.e21123","article-title":"Safety, efficacy, pharmacokinetics of uliledlimab alone or combined with toripalimab in advanced solid tumor: initial results of a phase I\/II study","volume":"14","author":"Zhou","year":"2022","journal-title":"Am Soc Of Clin Oncol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.2570","article-title":"Uliledlimab and toripalimab combination therapy in treatment naive advanced NSCLC: phase 1b\/2 clinical trial results using CD73 as a potential predictive biomarker","volume":"31","author":"Zhou","year":"2023","journal-title":"Am Soc Of Clin Oncol"},{"key":"B147","unstructured":"Pipeline\n          \n          \n          \n          2024"},{"key":"B148","doi-asserted-by":"publisher","first-page":"4453","DOI":"10.1158\/1538-7445.AM2019-4453","article-title":"Abstract 4453: novel, potent, and selective small-molecule inhibitors modulating immuno-oncology targets CD73, A2a\/A2b adenosine receptors and csf1r discovered via dna-encoded library screening","volume":"79","author":"Hupp","year":"2019","journal-title":"Cancer Res"},{"key":"B149","doi-asserted-by":"publisher","first-page":"116672","DOI":"10.1016\/j.bmc.2022.116672","article-title":"Discovery and optimization of betulinic acid derivatives as novel potent CD73 inhibitors","volume":"59","author":"Zhang","year":"2022","journal-title":"Bioorg Med Chem"},{"key":"B150","doi-asserted-by":"publisher","first-page":"109112","DOI":"10.1016\/j.steroids.2022.109112","article-title":"Application of A fluorine strategy in the lead optimization of betulinic acid to the discovery of potent CD73 inhibitors","volume":"188","author":"Zhang","year":"2022","journal-title":"J Steroids"},{"key":"B151","unstructured":"Product pipeline\n          \n          \n            \n              Limited\n              GB\n            \n          \n          \n          2024"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6215.TACPAD22-IA013","article-title":"Abstract ia013: preclinical testing of CD73 inhibitors for pancreatic cancer immunoprevention","volume":"15","author":"Ballew","year":"2022","journal-title":"J Cancer Prev Res"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-21-0802","article-title":"Targeting CD73 with ab680 (Quemliclustat), A novel and potent small-molecule CD73 inhibitor, restores immune functionality and facilitates antitumor immunity","volume":"21","author":"Piovesan","year":"2022","journal-title":"Mol Cancer Ther"},{"key":"B154","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1158\/2326-6066.CIR-22-0260","article-title":"Cd73 inhibits cgas-sting and cooperates with cd39 to promote pancreatic cancer","volume":"11","author":"Jacoberger-Foissac","year":"2023","journal-title":"Cancer Immunol Res"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202302498","article-title":"Tumor microenvironment responsive cd8(+) T cells and myeloid-derived suppressor cells to trigger CD73 inhibitor ab680-based synergistic therapy for pancreatic cancer","volume":"10","author":"Chen","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.v24.18","article-title":"A novel antisense lncRNA NT5E promotes progression by modulating the expression of syncrip and predicts a poor prognosis in pancreatic cancer","volume":"24","author":"Zhang","year":"2020","journal-title":"J Cell Mol Med"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.7150\/jca.53385","article-title":"CircNT5E promotes the proliferation and migration of bladder cancer via sponging mir-502-5p","volume":"12","author":"Yang","year":"2021","journal-title":"J Cancer"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-0532","article-title":"Circnt5e acts as a sponge of mir-422a to promote glioblastoma tumorigenesis","volume":"78","author":"Wang","year":"2018","journal-title":"Cancer Res"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.18632\/aging.102861","article-title":"The circular rna nt5e promotes non-small cell lung cancer cell growth via sponging microrna-134","volume":"12","author":"Dong","year":"2020","journal-title":"Aging (Albany Ny)"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00285.2019","article-title":"Cell type- and tissue-specific functions of ecto-5\u2019-nucleotidase (CD73)","volume":"317","author":"Minor","year":"2019","journal-title":"Am J Physiol Cell Physiol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1515875\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T05:12:28Z","timestamp":1733980348000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1515875\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,12]]},"references-count":160,"alternative-id":["10.3389\/fimmu.2024.1515875"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1515875","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,12]]},"article-number":"1515875"}}